カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Thyrogen and Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7996）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7996
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のチロゲン&バイオシミラーの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のチロゲン&バイオシミラー市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- チロゲン&バイオシミラーの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

チロゲン&バイオシミラー市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・ブランド、バイオシミラー

用途別セグメント
・病院、薬局、その他

主要な市場プレーヤー
・Sanofi、Sato Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、チロゲン&バイオシミラー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なチロゲン&バイオシミラーメーカーの企業概要、2019年～2022年までのチロゲン&バイオシミラーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なチロゲン&バイオシミラーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別チロゲン&バイオシミラーの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのチロゲン&バイオシミラーのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのチロゲン&バイオシミラー市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびチロゲン&バイオシミラーの産業チェーンを掲載しています。
・第14、15章では、チロゲン&バイオシミラーの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– チロゲン&バイオシミラーの概要
– タイプ別分析（2018年vs2022年vs2029年）：ブランド、バイオシミラー
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局、その他
– 世界のチロゲン&バイオシミラー市場規模・予測
– 世界のチロゲン&バイオシミラー生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi、Sato Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：ブランド、バイオシミラー
・用途別分析2018年-2029年：病院、薬局、その他
・チロゲン&バイオシミラーの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・チロゲン&バイオシミラーのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・チロゲン&バイオシミラーのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・チロゲン&バイオシミラーの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・チロゲン&バイオシミラーの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Thyrogen and Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Thyrogen and Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Brand
1.3.3 Biosimilar
1.4 Market Analysis by Application
1.4.1 Overview: Global Thyrogen and Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Global Thyrogen and Biosimilar Market Size & Forecast
1.5.1 Global Thyrogen and Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Thyrogen and Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Thyrogen and Biosimilar Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Thyrogen and Biosimilar Product and Services
2.1.4 Sanofi Thyrogen and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 Sato Pharmaceutical
2.2.1 Sato Pharmaceutical Details
2.2.2 Sato Pharmaceutical Major Business
2.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Product and Services
2.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sato Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Thyrogen and Biosimilar by Manufacturer
3.1 Global Thyrogen and Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Thyrogen and Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Thyrogen and Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Thyrogen and Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Thyrogen and Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Thyrogen and Biosimilar Manufacturer Market Share in 2022
3.5 Thyrogen and Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Thyrogen and Biosimilar Market: Region Footprint
3.5.2 Thyrogen and Biosimilar Market: Company Product Type Footprint
3.5.3 Thyrogen and Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Thyrogen and Biosimilar Market Size by Region
4.1.1 Global Thyrogen and Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Thyrogen and Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Thyrogen and Biosimilar Average Price by Region (2018-2029)
4.2 North America Thyrogen and Biosimilar Consumption Value (2018-2029)
4.3 Europe Thyrogen and Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Thyrogen and Biosimilar Consumption Value (2018-2029)
4.5 South America Thyrogen and Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Thyrogen and Biosimilar Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Thyrogen and Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Thyrogen and Biosimilar Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Thyrogen and Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Thyrogen and Biosimilar Average Price by Application (2018-2029)
7 North America
7.1 North America Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Thyrogen and Biosimilar Market Size by Country
7.3.1 North America Thyrogen and Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Thyrogen and Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Thyrogen and Biosimilar Market Size by Country
8.3.1 Europe Thyrogen and Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Thyrogen and Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Thyrogen and Biosimilar Market Size by Region
9.3.1 Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Thyrogen and Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Thyrogen and Biosimilar Market Size by Country
10.3.1 South America Thyrogen and Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Thyrogen and Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Thyrogen and Biosimilar Market Size by Country
11.3.1 Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Thyrogen and Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Thyrogen and Biosimilar Market Drivers
12.2 Thyrogen and Biosimilar Market Restraints
12.3 Thyrogen and Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Thyrogen and Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Thyrogen and Biosimilar
13.3 Thyrogen and Biosimilar Production Process
13.4 Thyrogen and Biosimilar Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Thyrogen and Biosimilar Typical Distributors
14.3 Thyrogen and Biosimilar Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Thyrogen and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Thyrogen and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Thyrogen and Biosimilar Product and Services
Table 6. Sanofi Thyrogen and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. Sato Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Sato Pharmaceutical Major Business
Table 10. Sato Pharmaceutical Thyrogen and Biosimilar Product and Services
Table 11. Sato Pharmaceutical Thyrogen and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sato Pharmaceutical Recent Developments/Updates
Table 13. Global Thyrogen and Biosimilar Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 14. Global Thyrogen and Biosimilar Revenue by Manufacturer (2018-2023) & (USD Million)
Table 15. Global Thyrogen and Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Market Position of Manufacturers in Thyrogen and Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 17. Head Office and Thyrogen and Biosimilar Production Site of Key Manufacturer
Table 18. Thyrogen and Biosimilar Market: Company Product Type Footprint
Table 19. Thyrogen and Biosimilar Market: Company Product Application Footprint
Table 20. Thyrogen and Biosimilar New Market Entrants and Barriers to Market Entry
Table 21. Thyrogen and Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Thyrogen and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 23. Global Thyrogen and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 24. Global Thyrogen and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 25. Global Thyrogen and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 26. Global Thyrogen and Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 27. Global Thyrogen and Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 28. Global Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 30. Global Thyrogen and Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 31. Global Thyrogen and Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 32. Global Thyrogen and Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 33. Global Thyrogen and Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 34. Global Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 35. Global Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 36. Global Thyrogen and Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 37. Global Thyrogen and Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 38. Global Thyrogen and Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 39. Global Thyrogen and Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 40. North America Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 41. North America Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 42. North America Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 43. North America Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 44. North America Thyrogen and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 45. North America Thyrogen and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 46. North America Thyrogen and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 47. North America Thyrogen and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 48. Europe Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Europe Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Europe Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 51. Europe Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 52. Europe Thyrogen and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 53. Europe Thyrogen and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 54. Europe Thyrogen and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 55. Europe Thyrogen and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 56. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 57. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 58. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 59. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 60. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 61. Asia-Pacific Thyrogen and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 62. Asia-Pacific Thyrogen and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 63. Asia-Pacific Thyrogen and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 64. South America Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 65. South America Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 66. South America Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 67. South America Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 68. South America Thyrogen and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 69. South America Thyrogen and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 70. South America Thyrogen and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 71. South America Thyrogen and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 72. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 73. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 74. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 77. Middle East & Africa Thyrogen and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 78. Middle East & Africa Thyrogen and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 79. Middle East & Africa Thyrogen and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 80. Thyrogen and Biosimilar Raw Material
Table 81. Key Manufacturers of Thyrogen and Biosimilar Raw Materials
Table 82. Thyrogen and Biosimilar Typical Distributors
Table 83. Thyrogen and Biosimilar Typical Customers
List of Figures
Figure 1. Thyrogen and Biosimilar Picture
Figure 2. Global Thyrogen and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Thyrogen and Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Brand Examples
Figure 5. Biosimilar Examples
Figure 6. Global Thyrogen and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Thyrogen and Biosimilar Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Other Examples
Figure 11. Global Thyrogen and Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Thyrogen and Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Thyrogen and Biosimilar Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Thyrogen and Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Thyrogen and Biosimilar Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Thyrogen and Biosimilar Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Thyrogen and Biosimilar by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Thyrogen and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Thyrogen and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Thyrogen and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Thyrogen and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Thyrogen and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Thyrogen and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Thyrogen and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Thyrogen and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Thyrogen and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Thyrogen and Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Thyrogen and Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Thyrogen and Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Thyrogen and Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Thyrogen and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Thyrogen and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Thyrogen and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Thyrogen and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Thyrogen and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Thyrogen and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 53. China Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Thyrogen and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Thyrogen and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Thyrogen and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Thyrogen and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Thyrogen and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Thyrogen and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Thyrogen and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Thyrogen and Biosimilar Market Drivers
Figure 74. Thyrogen and Biosimilar Market Restraints
Figure 75. Thyrogen and Biosimilar Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Thyrogen and Biosimilar in 2022
Figure 78. Manufacturing Process Analysis of Thyrogen and Biosimilar
Figure 79. Thyrogen and Biosimilar Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアバスチンバイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のエンブレル（エタネルセプト）バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のベバシズマブモノクローナル抗体バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアダリムマブモノクローナル抗体バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のレミケード（インフリキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7996 )"世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Thyrogen and Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。